INTRODUCTION
============

The primary treatment modalities for head and neck cancer (HNC) include surgery and radiotherapy, with an increasing role for chemotherapy and targeted molecular therapies. Treatment has intensified to improve local tumor control and survival rates. Unfortunately, these aggressive treatments can result in swallowing dysfunction. Silent aspiration and pneumonia were reported in 17 to 81% of patients with stage III and IV HNC. Additionally, long-term tube feeding was reported in as many as 30% of patients.[@B1][@B2] Dysphagia and aspiration are long-term complications with life threatening consequences following treatment of HNC. Swallowing problems have a multifactorial and complex etiology, and current insight into the prevalence of swallowing dysfunction in HNC patients is still limited.

The purposes of this study were to evaluate specific dysphagia patterns by using a modified barium swallow (MBS) test and to identify the factors affecting dysphagia, especially aspiration, following treatment of head and neck cancer.

MATERIALS AND METHODS
=====================

A retrospective analysis was performed on 57 patients who were referred to our department complaining of dysphagia symptoms following treatment of HNC since 2008. Patients were selected if they were local and regional cancer free at their MBS test. Patients who had any history of cerebrovascular disease that affected swallowing were excluded.

Patient, tumor, and treatment characteristics are detailed in [Table 1](#T1){ref-type="table"}. The mean age at the time of the MBS test was 62.21 (range, 34-83) years. Thirty-three (57.9%) patients were over 65 years of age. The oropharynx and glottis were the most common primary tumor sites. Dysphagia/aspiration related structures (DARS)[@B3] include the base of the tongue (BOT), pharyngeal constrictors, larynx, and the autonomic neural complex. In this study, 36 patients had primary tumors in DARS. About 70% of the patients had higher clinical stage disease. Various treatment modalities for HNC were used and radiotherapy was performed in 71.9% (n=41) of the patients. In the surgery groups, 65.9% (n=32) of the patients underwent adjuvant treatment with radiation and/or chemotherapy. Twenty-seven patients were able to consume a general diet and 20 patients were dependent on tube feeding at initial assessment.

Patients who complained of any dysphagia symptoms were evaluated by physical examination of the head and neck region including laryngoscopy and a sequential MBS test in an upright position. During the MBS test, thin liquids were administered to all subjects with increasing volume (1, 3, 5, 10 cc), and food items of different consistencies were presented at the discretion of an otolaryngologist and speech pathologist.

Penetration was defined as passage of material into the larynx without passing below the vocal folds. Aspiration was defined as passage of material below the level of the vocal folds.[@B4] We recorded and checked the presence or absence of penetration, aspiration (sensate or silent), residue, and abnormal patterns of the pharyngeal phase: reduced BOT retraction, delayed pharyngeal swallowing, pharyngeal contraction weakness, reduced hyolaryngeal elevation, and cricopharyngeal (CP) dysfunction during the MBS test. During the examination, once the problem was identified, compensatory maneuvers such as postural change or alterations in swallowing behavior were taught to lessen the problem, and dynamic examination was performed. After performing the MBS test, findings were rated on an 8-point penetration and aspiration scale (PAS)[@B4] and given a swallowing performance score (SPS) of 1 to 7. In PAS, the clinician\'s rating for each swallow trial considered the bolus path, depth of penetration/aspiration, and patient response ([Table 2](#T2){ref-type="table"}).[@B4] Patients with a SPS of 3 or 4 require diet modification and/or a swallowing maneuver. A score of more than 5 suggests a risk of aspiration, while a score of 7 indicates a need for primary tube feeding. Patients with an abnormal swallow (SPS of 3-7) were instructed on compensatory and/or rehabilitative maneuvers. Surgical interventions, such as injection laryngoplasty, bougienation, botox injection to the CP muscle, or CP myotomy, were also utilized. A mean of 27.98 (SD, 42.93) months elapsed between treatment and MBS tests.

The study was approved by the Institutional Review Board of The Catholic University of Korea.

Statistics
----------

Statistical analysis was performed with Student\'s t-test or the Mann-Whitney U-test, the chi-square test or Fisher\'s exact test, and analysis of variance using SPSS version 18.0 for Windows (SPSS Inc., Chicago, IL, USA). All *p*-values less than 0.05 were deemed statistically significant.

RESULTS
=======

MBS findings
------------

Reduced BOT retraction (64.9%), reduced laryngeal elevation (57.9%), and CP dysfunction (47.4%) were frequently found on MBS tests ([Table 3](#T3){ref-type="table"}). Aspiration and penetration were observed in 42.1% (n=24) and 33.3% (n=19) of all tested patients, respectively. Among aspirating patients, aspiration after swallowing was the most common pattern, observed in 60.9% (n=14) of patients.

The abnormal swallowing patterns on MBS between patients with primaries in DARS and patients with primaries at other locations did not differ significantly in this study (*p*=0.650).

We confirmed whether residue remained in the vallecula, pyriform sinus, or both sites. Residue was found in 32 patients: eight in the vallecula, seven in the pyriform sinus, and 17 in both sites. Residue was identified frequently in patients with reduced BOT retraction (*p*\<0.001), reduced laryngeal elevation (*p*\<0.001), and CP dysfunction (*p*\<0.001) ([Table 4](#T4){ref-type="table"}).

Reduced BOT retraction was the most common dysphagia pattern and was correlated with clinical stage (*p*=0.011) and treatment modality (*p*=0.001). Higher stage (III-IV) disease (21/31, 67.7%) and treatment including radiotherapy (32/41, 78.0%) were significantly associated with reduced BOT retraction. When MBS showed reduced BOT retraction, coexisting residue \[relative risk (RR)=5.22\], reduced laryngeal elevation (RR=5.405), or CP dysfunction (RR=6.756) were also found.

Radiotherapy was performed more frequently in patients with stage III-IV disease (26/31, 83.9%) than in patients with stage I-II disease (6/14, 42.9%) (*p*=0.005). Abnormal swallowing was significantly different between groups with or without radiotherapy. Aspiration (*p*=0.784), penetration (*p*=0.537), and PAS (*p*=0.660) did not differ between patients with radiotherapy and those without. However, patients who underwent radiotherapy were significantly more likely to have reduced BOT retraction (32/41, 86.5%) than those who did not (5/16, 13.5%) (*p*=0.001). Residue was also found significantly more often (*p*=0.076) in patients who underwent radiotherapy (26/41, 81.2%) than in those who did not (6/16, 18.8%). Even among surgery groups, MBS findings were significantly different between patients with or without adjuvant treatment that included radiotherapy. Patients who underwent adjuvant treatment were significantly (*p*=0.004) more likely to have reduced BOT retraction (23/31, 82.1%) than those who did not (5/16, 17.9%).

The distributions of PAS and SPS values are shown in [Fig. 1](#F1){ref-type="fig"}. Twenty-four (42%) patients had PAS values over 6, implying aspiration. Forty-one (71.9%) patients had a score of more than 3; 25 (43.9%) patients had a score greater than 5; and 13 patients had a SPS score of more than 7.

Characteristics of tube feeders
-------------------------------

Characteristics more frequent in patients (n=20) who had to be fed via a tube at the initial visit than in patients with an oral diet were older age (65.0%), DARS primaries (75.0%), higher stage disease (66.7%), and history of radiotherapy (68.8%). MBS results in tube feeders were reduced BOT retraction (85.0%), reduced laryngeal elevation (95.0%), CP dysfunction (75.0%), aspiration (75.0%), and residue (75.0%) in most patients. Among 20 tube feeders, only 13 patients had a SPS score of 7 at the initial visit. The other seven patients were able to eat orally with the help of diet modification and management.

Aspiration
----------

Aspiration was not significantly related to primary site (*p*=0.654), DARS (*p*=0.166), stage (*p*=0.478), radiotherapy (*p*=0.784), or adjuvant treatment (*p*=0.936). Aspiration was found more frequently in patients who had penetration (13/19, 68.4%) than in patients who did not (10/38, 26.3%) (*p*=0.002).

Age was a factor affecting aspiration in HNC patients (*p*=0.026). We divided the patients into those above and below 65 years old. Primary site, clinical stage, treatments, and feeding status at baseline did not differ significantly. However, aspiration, higher PAS, and higher SPS were found at a significantly higher rate in the older age group ([Table 5](#T5){ref-type="table"}). To identify risk factors for aspiration independent of age, we investigated aspiration in each age group separately. In the middle age group, a SPS score of more than 5 on MBS test was the only factor affecting aspiration (*p*\<0.001). In the older age group, almost all abnormal findings on MBS, including reduced BOT retraction, delayed pharyngeal swallow, pharyngeal contraction weakness, reduced hyolaryngeal elevation, CP dysfunction, penetration, and even a SPS score over 3, were significantly correlated to aspiration ([Table 6](#T6){ref-type="table"}).

DISCUSSION
==========

Swallowing comprises four stages: oral preparatory, oral, pharyngeal, and esophageal. After the voluntary oral phases of swallowing, an involuntary reflex requiring fast and precise coordination between sensory input and motor function occurs.[@B5][@B6] Since, dysphagia is a nonspecific diagnosis, we performed a MBS test on patients and calculated PAS and SPS scores to better understand the clinical manifestations of dysphagia. Objective assessment of swallowing function and safety is frequently performed using videofluoroscopic swallowing study, often referred to as a MBS test, which is a validated instrument developed by Logemann, et al.[@B7] The test facilitates radiographic assessment of the structures and dynamics involved in all phases of the swallowing process. The findings of a MBS test are scored using SPS, which provides an accurate assessment of the presence and severity of dysphagia and aspiration risk by combining clinical and radiographic data, and PAS, which encompasses an 8 point, equal appearing interval scale to describe penetration and aspiration events.[@B4]

Factors affecting the risk of dysphagia in HNC patients have been reported, and include primary site, treatment modality, age, gender, and comorbidity.[@B8] Patients with oropharyngeal and hypopharyngeal cancers reportedly show the greatest risk of post-treatment dysphagia.[@B9] In our study, there was no significant difference in dysphagia and pattern between patients with DARS and non-DARS primaries. Primary site did not seem to impact the course of dysphagia in this study. However, tube feeders were found more often in DARS primaries.

Since the introduction of chemo-radiotherapy, which showed a similar efficacy to that of surgery and adjuvant radiation,[@B10] dysphagia and its sequelae have been increasing.[@B11] Late effects may persist months or years after radiotherapy.[@B12][@B13] Post-radiation edema and radiation-induced fibrosis lead to reduced tissue compliance and immobility of underling muscles. The severity of radiation-induced dysphagia is dependent on total radiation dose, fraction size and schedule, target volumes, treatment delivery techniques, concurrent chemotherapy, genetic factors, presence of a percutaneous endoscopic gastrostomy tube or nil per os status, smoking, and psychological coping factors.[@B14] In one report, dysphagia was not isolated to treatment with chemo-radiotherapy. In fact, compared to surgery alone, patients treated with all other regimens had higher risks of dysphagia. The risk of swallowing dysfunction was increased for any regimen involving radiotherapy.[@B8] In our study, the most common abnormal pattern observed in the pharyngeal phase was reduced BOT retraction, and patients who underwent radiotherapy were significantly more likely to have reduced BOT retraction and also had more residues on the test. Reduced BOT retraction leads to residue, particularly in the vallecula region, and increases the risk of aspiration after the swallow,[@B15] which was the most common aspiration pattern seen in this study. Ultimately, reduction of BOT retraction by radiotherapy and its associated phenomena increase the risk of aspiration.

Aspiration remains a significant morbidity following HNC treatment. Its prevalence is underreported in the literature because of its often silent nature.[@B16] Silent aspiration and pneumonia was reported in 17 to 81% of patients with stage III-IV HNC. Moreover, long-term use of tube nutrition was reported in as many as 30% of patients.[@B1][@B2] In our study, only in 13 (22.8%) patients showed a SPS score of 7 and needed tube feeding at the initial assessment. However, before evaluation, 20 patients reported that they were exclusively dependent on tube feeding. The 7 patients who previously experienced tube feeding did not know that they could eat by mouth before having the test. Tube feeding is time-consuming and is associated with significant costs.[@B17]

In our study, when abnormal MBS findings were present, the aspiration rate was lower in the middle age group than in the older age group. In contrast, the aspiration rate was much higher in each abnormal swallowing step in the older age group than the middle age group irrespective of disease stage or treatment. Even a SPS score above 3 affected risk of aspiration in the older age group. In one study, even healthy older adults experienced dysphagia and occasional aspiration[@B18] and had a greater duration of CP opening than younger adults.[@B19] Therefore, in older HNC patients, swallowing evaluation is mandatory irrespective of tumor stage or treatment to identify the patterns of dysphagia and severity in order to provide proper management and to prevent unnecessary tube feeding.

The limitations of our study included the absence of a baseline swallowing study, its retrospective nature, and the selection factors, as only patients who complained of dysphagia underwent a MBS test. Dysphagia may also have been present prior to therapy. Logemann, et al.[@B20] reported a prevalence of pre-treatment dysphagia of 28.2% in patients with oral cancer of stage T2 or above, 50.9% in pharyngeal cancer, and 28.6% in laryngeal cancer. Dysphagia caused by a tumor and increased age may be associated with increased baseline swallowing dysfunction.[@B21] Thus, objective dysphagia testing is recommended before, during, and after treatment in HNC patients.

In summary, reduced BOT retraction was the most common dysphagia pattern and BOT retraction was correlated with clinical stage and treatment regimens that included radiotherapy. Reduction of BOT retraction by radiotherapy and its associated phenomena increase the risk of aspiration. In older patients, aspiration risk was much higher than in younger patients and even single stage abnormality in any swallowing step caused aspiration irrespective of disease stage or treatment. Proper swallowing evaluation, such as a MBS test, should be mandatory, especially in older HNC patients, irrespective of disease stage or treatment, and patients with a higher stage disease who have undergone radiotherapy to identify the exact dysphagia pattern in order to provide proper rehabilitation and to avoid unnecessary tube feeding. With this study, further evidence based studies on the effect of BOT exercises before, during, and after treatment in HNC patients are needed. Also, further studies that describe dysphagia should use more specific scoring systems, such as PAS and SPS, to standardize degree of dysphagia.
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![Penetration-aspiration scale (PAS) and swallowing performance score (SPS) determined via MBS. Twenty-four (42%) patients had a PAS score over 6, implying aspiration. Patients with a SPS score over 5 are at risk of aspiration and those with a score of 7 absolutely require primary tube feeding. Twenty-five (43.9%) patients had a score over 5 and 13 patients had a score of 7. MBS, modified barium swallow.](ymj-56-1221-g001){#F1}

###### Patient, Tumor, and Treatment Characteristics

![](ymj-56-1221-i001)

                             Number of patients (n=57)   \%
  -------------------------- --------------------------- -----------------
  Gender (men:women)         48:9                        84.2:15.8
  Age (yrs)                  62.21 (SD, 10.94)           (Range, 34-83)
  Middle age:older age       24:33                       42.1:57.9
  Primary sites                                          
   Oral cavity               7                           12.3
   Oropharynx                15                          26.3
   Hypopharynx               2                           3.5
   Supraglottis              3                           5.3
   Glottis                   15                          26.3
   Thyroid                   7                           12.3
   Others^\*^                8                           14.0
  T-classification (n=43)                                
   1-2                       25                          58.1
   3-4                       18                          41.9
  N-classification (n=44)                                
   Negative                  23                          52.3
   Positive                  21                          47.7
  M-classification (n=44)                                
   Negative                  40                          90.9
   Positive                  4                           9.1
  AJCC stage (n=45)                                      
   I to II                   14                          31.1
   III to IV                 31                          68.9
  Treatment                                              
   Surgery alone             16                          28.1
   Surgery with RT           18                          31.6
   Surgery with CCRT         14                          24.6
   RT alone                  4                           7.0
   CCRT                      5                           8.8
  Pathology (n=50)                                       
   SCC:non-SCC               36:14                       72.0:28.0
  Diet                                                   
   Oral general              27                          47.4
   Oral soft                 9                           15.8
   Oral liquid               1                           1.8
   Tube feeding              20                          35.1
  Time of MBS test (month)   27.98 (SD, 42.93)           (Range, 11-196)

AJCC, American Joint Committee on Cancer, 2002; RT, radiation therapy; CCRT, concomitant chemo-radiotherapy; SCC, squamous cell carcinoma; MBS, modified barium swallow.

^\*^1 lower eyelid cancer, 4 nasopharyngeal cancers, 1 parapharyngeal cancer, and 2 esophageal cancers.

###### Eight-Point Penetration-Aspiration Scale
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  --- --------------------------------------------------------------------------------------------------------------
  1   Material dose not enter the airway
  2   Material enters the airway, remains above the vocal folds, and is ejected from the airway
  3   Material enters the airway, remains above the vocal folds, and is not ejected from the airway
  4   Material enters the airway, contacts the vocal folds, and is ejected from the airway
  5   Material enters the airway, contacts the vocal folds, and is not ejected from the airway
  6   Material enters the airway, passes below the vocal folds and is ejected into the larynx or out of the airway
  7   Material enters the airway, passes below the vocal folds, and is not ejected from the trachea despite effort
  8   Material enters the airway, passes below the vocal folds, and no effort is made to eject
  --- --------------------------------------------------------------------------------------------------------------

###### MBS Findings Following Treatment of Head and Neck Cancer
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                           Normal (%)   Abnormal (%)
  ------------------------ ------------ --------------
  Lip closure              56 (98.2)    1 (1.8)
  Tongue movement          49 (86.0)    8 (14.0)
  Velopharyngeal closure   52 (91.2)    5 (8.8)
  BOT retraction           20 (35.1)    37 (64.9)
  Pharyngeal swallow       44 (77.2)    13 (22.8)
  Pharyngeal contraction   42 (73.7)    15 (26.3)
  Hyolaryngeal elevation   24 (42.1)    33 (57.9)
  CP function              30 (52.6)    27 (47.4)

MBS, modified barium swallow; BOT, base of the tongue; CP, cricopharyngeal.

###### Relationship between Residue and MBS Findings
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                                No residue (n=25)   Residue (n=32)   *p* value
  ----------------------------- ------------------- ---------------- -----------
  Normal BOT retraction         17                  3                \<0.001
  Reduced BOT retraction        8                   29               
  Normal laryngeal elevation    19                  5                \<0.001
  Reduced laryngeal elevation   6                   27               
  Normal CP function            22                  8                \<0.001
  CP dysfunction                3                   24               

MBS, modified barium swallow; BOT, base of the tongue; CP, cricopharyngeal.

###### Relationship between Age and Aspiration
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                  Middle age (n=24)   Older age (n=33)   *p* value
  --------------- ------------------- ------------------ -----------
  No aspiration   18                  15                 0.026
  Aspiration      6                   18                 
  PAS 1-5         18                  15                 0.026
  PAS 6-8         6                   18                 
  SPS 1-4         17                  15                 0.057
  SPS 5-7         7                   18                 

PAS, penetration and aspiration scale; SPS, swallowing performance score.

###### The Rate of Aspiration According to Abnormal Swallowing Pattern in Each Age Group
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  MBS test findings                 Middle age    Older age                  
  --------------------------------- ------------- ----------- -------------- ---------
  Reduced BOT retraction            3/14 (21.4)   1.000       15/23 (65.2)   0.060
  Delayed pharyngeal swallow        1/5 (20.0)    0.521       9/10 (90.0)    0.009
  Pharyngeal contraction weakness   2/9 (22.2)    1.000       6/6 (100)      0.021
  Reduced HL elevation              5/14 (35.7)   0.069       14/19 (73.7)   0.015
  CP dysfunction                    4/9 (44.4)    0.092       13/18 (72.2)   0.025
  Penetration                       3/7 (42.9)    0.126       10/12 (83.3)   0.027
  SPS≥3                             5/16 (31.3)   0.130       18/25 (72.0)   \<0.001
  SPS≥5                             5/7 (71.4)    \<0.001     18/18 (100)    \<0.001

MBS, modified barium swallow; BOT, base of the tongue; HL, hyolaryngeal; CP, cricopharyngeal; SPS, swallowing performance score.
